Intra-Aortic Balloon Pump (IABP) Market Research, 2033
The global intra-aortic balloon pump (IABP) market size was valued at $351.2 million in 2023, and is projected to reach $528.2 million by 2033, growing at a CAGR of 4.2% from 2024 to 2033. The intra-aortic balloon pump (IABP) market is driven by the increasing prevalence of cardiovascular diseases, the growing geriatric population, and the rising demand for minimally invasive surgical procedures. Additionally, advancements in IABP technology, such as improved balloon design and monitoring capabilities, are enhancing patient outcomes and expanding their clinical applications.
Market Introduction and Definition
An intra-aortic balloon pump (IABP) is a medical device used to support patients with severe cardiac conditions, particularly those experiencing heart failure, cardiogenic shock, or during high-risk cardiac procedures such as coronary artery bypass grafting (CABG) or percutaneous coronary interventions (PCI) . The IABP consists of a large, inflatable balloon positioned in the aorta, the main artery leading from the heart. This balloon is connected to a console that controls its inflation and deflation cycles.
The primary function of the IABP is to enhance coronary blood flow and reduce the workload on the heart. During diastole (when the heart relaxes) , the balloon inflates, which increases blood flow to the coronary arteries and improves oxygen delivery to the heart muscle. Conversely, during systole (when the heart contracts) , the balloon rapidly deflates, reducing aortic pressure and allowing the heart to eject blood more easily. This dual action helps to improve cardiac output, stabilize hemodynamics, and can be crucial in managing patients with acute coronary syndromes or those undergoing major cardiac surgery.
Key Takeaways
- The intra-aortic balloon pump market study covers 20 countries. The research includes a segment analysis of each country in terms of value ($Million) for the projected period 2023-2033.
- More than 1, 500 product literatures, industry releases, annual reports, and other such documents of major intra-aortic balloon pump (IABP) industry participants along with authentic industry journals, trade associations' releases, and government websites have been reviewed for generating high-value industry insights.
- The study integrated high-quality data, professional opinions and analysis, and critical independent perspectives. The research approach is intended to provide a balanced view of global markets and to assist stakeholders in making educated decisions in order to achieve their most ambitious growth objectives.
Key Market Dynamics
The intra-aortic balloon pump (IABP) market size is driven by several key factors. The rising prevalence of cardiovascular diseases (CVDs) , particularly among the aging population, is a significant driver, as IABPs are crucial for managing conditions like cardiogenic shock and heart failure. According to the World Health Organization (WHO) , CVDs account for approximately 32% of all global deaths, creating a robust demand for advanced cardiac support devices. Additionally, technological advancements, such as the development of portable and more efficient IABP systems, have enhanced patient outcomes and expanded the use of IABPs in various clinical settings.
However, the market faces restraints during intra-aortic balloon pump (IABP) market forecast, including high costs associated with IABP devices and procedures. The initial investment and maintenance costs can be prohibitive for smaller healthcare facilities, potentially limiting market growth. Furthermore, the availability of alternative therapies, such as ventricular assist devices (VADs) and extracorporeal membrane oxygenation (ECMO) , may also pose challenges to IABP adoption.
Despite these challenges, significant intra-aortic balloon pump (IABP) market opportunity exist within the IABP market. The increasing focus on improving patient care and outcomes has led to a rise in the adoption of IABPs in emerging economies, where healthcare infrastructure is rapidly evolving. For instance, the Asia-Pacific region is expected to witness a CAGR of over 7% from 2023 to 2030, fueled by improving healthcare facilities and increasing investments in medical technologies. Additionally, the integration of artificial intelligence and telemedicine in IABP systems presents an opportunity to enhance monitoring and management, further driving intra-aortic balloon pump (IABP) market growth.?
Market Segmentation
The intra-aortic balloon pump industry is segmented into product, indication, end-user and region. On the basis of product, the market is bifurcated into intra-aortic balloon pump catheter and intra-aortic balloon pump console. Based on indication, the market is divided into coronary artery disease and chronic heart failure. Based on end user, the market is divided into hospitals, ambulatory surgical centers, and others. Region-wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Regional/Country Market Outlook
North America holds the largest intra-aortic balloon pump (IABP) market share due to several key factors. Firstly, the region has a high prevalence of cardiovascular diseases, including coronary artery disease and heart failure, which necessitate advanced medical interventions like IABPs. The aging population in North America further contributes to the growing demand, as older individuals are more susceptible to heart-related conditions.
Additionally, the presence of well-established healthcare infrastructure, along with significant investments in medical technologies and innovations, enhances the availability and adoption of IABPs in clinical settings further drive intra-aortic balloon pump (IABP) market growth.
Furthermore, North America benefits from a high rate of healthcare expenditure, enabling hospitals and healthcare facilities to procure advanced medical devices. The strong focus on research and development in the region also fosters the continuous improvement and introduction of cutting-edge IABP technologies, reinforcing its dominant market position.
Industry Trends
- Innovations in IABP technology, such as improved balloon design, enhanced monitoring systems, and miniaturization, have contributed to their effectiveness and adoption in clinical settings.
- With the increasing prevalence of coronary artery disease, heart failure, and other cardiovascular conditions, the demand for IABPs has surged.
Patent Analysis, By Country, 2015-2024
U.S. witnessed the highest number of patent approvals and applications, due to favorable government policies, new technological advancement and new service and software launches in the country. European Patent Office has 16.2% of the total number of patents, followed by PCT at 12.4%.
Competitive Landscape
The major intra-aortic balloon pump (IABP) market share players operating in the market include Abbott Laboratories, Getinge AB, Maquet Cardiovascular, CardiacAssist, Inc., Teleflex Incorporated, Bard Peripheral Vascular, Medtronic plc, LivaNova PLC, Terumo Corporation and Boston Scientific Corporation. Other key players include Fresenius SE & Co. KGaA, Parker Hannifin Corporation, Schneider Electric, Elekta AB and so on.
Recent Key Strategies and Developments
- In July 2021, MAQUET Holding announced the launch of its new CARDIOSAVE Hybrid Intra-Aortic Balloon Pump (IABP) System in Europe.
- In March 2021, Getinge announced the launch of its new Maquet Cardiosave IABP with IntelliSync+ Console System in the U.S.
- In February 2021, Medtronic announced the launch of its new SenSight Directional Mechanical Lead for the Attain Stability Quad MRI SureScan Left Heart Lead.
Key Benefits For Stakeholders
- This intra-aortic balloon pump (IABP) market report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the Intra-aortic balloon pump (IABP) market analysis from 2023 to 2033 to identify the prevailing Intra-aortic balloon pump (IABP) market opportunities.
- The market research is offered along with information related to key drivers, restraints, and opportunities.
- Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
- In-depth analysis of the Intra-aortic balloon pump (IABP) market segmentation assists to determine the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the global Intra-aortic balloon pump (IABP) market statistics.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
- The report includes the analysis of the regional as well as global Intra-aortic balloon pump (IABP) market trends, key players, market segments, application areas, and market growth strategies.
Key Sources Referred
- Centers for Disease Control and Prevention
- World Health Organization
- National Center for Biotechnology Information
- The Lancet
- National Perinatal Epidemiology and Statistics Unit (NPESU)
- Science Direct
- Health Resources and Services Administration (HRSA)
- Department of Health and Human Services (HHS)
- National Institutes of Health (NIH)
Intra-Aortic Balloon Pump Report Highlights
| Aspects | Details |
 Market Size By 2033 | USD 528.2 Million |
 Growth Rate | CAGR of 4.2% |
 Forecast period | 2024 - 2033 |
 Report Pages | 260 |
 By Product |
|
 By Indication |
|
 By End User |
|
 By Region |
|
 Key Market Players | LivaNova PLC, Boston Scientific Corporation, Getinge AB, CardiacAssist, Inc., Maquet Cardiovascular, Terumo Corporation, Teleflex Incorporated, Medtronic plc, Bard Peripheral Vascular Inc., Abbott Laboratories |
The Abbott Laboratories, Getinge AB, Maquet Cardiovascular, CardiacAssist, Inc., Teleflex Incorporated, Bard Peripheral Vascular held a high market position in 2023.
The base year is 2023 in intra-aortic balloon pump (IABP) market.
The forecast period for intra-aortic balloon pump (IABP) market is 2024 to 2033.
The market value of intra-aortic balloon pump (IABP) market is projected to reach $528.2 billion by 2033.
The total market value of intra-aortic balloon pump (IABP) market was $351.2 million in 2023.
Loading Table Of Content...
